Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Suthasinee Sinawat, Suthasinee Hemanak, Kwanchanok Chanthowong, Supat Sinawat & Yosanan Yospaiboon. (2023) Intravitreal Ziv-Aflibercept versus Bevacizumab for Naïve Central Retinal Vein Occlusion with Macular Edema: An Interim Analysis of a Randomized Non-Inferiority Trial. Clinical Ophthalmology 17, pages 2719-2728.
Read now
Read now
Faye Horner, Peck Lin Lip, Bushra Mushtaq, Randhir Chavan, Bashar Mohammed & Arijit Mitra. (2020) Combination Therapy for Macular Oedema in Retinal Vein Occlusions: 3-Year Results from a Real-World Clinical Practice. Clinical Ophthalmology 14, pages 955-965.
Read now
Read now
Josep Callizo, Focke Ziemssen, Thomas Bertelmann, Nicolas Feltgen, Jessica Vögeler, Mirja Koch, Nicole Eter, Sandra Liakopoulos, Steffen Schmitz-Valckenberg & Georg Spital. (2019) Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study. Clinical Ophthalmology 13, pages 2167-2179.
Read now
Read now
Kazuyuki Kumagai, Nobuchika Ogino, Marie Fukami & Mariko Furukawa. (2019) Vitrectomy for macular edema due to retinal vein occlusion. Clinical Ophthalmology 13, pages 969-984.
Read now
Read now
lias Georgalas, Ioannis Tservakis, Eftychia Eleftheria Kiskira, Petros Petrou, Dimitris Papaconstantinou & Menelaos Kanakis. (2019) Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study. Cutaneous and Ocular Toxicology 38:4, pages 330-337.
Read now
Read now
Articles from other publishers (31)
Lars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, Karen Basu, Carl J. Danzig, Robyn Guymer, Zdenka Haskova, Jeffrey S. Heier, Aachal Kotecha, Ying Liu, Anat Loewenstein, András Seres, Jeffrey R. Willis, Charles C. Wykoff & Liliana P. Paris. (2023) BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion. Ophthalmology Science 3:3, pages 100302.
Crossref
Crossref
Yasha S. Modi, Lediana Goduni, Hadi Moini, Andrea Gibson, Nick Boucher, Genevieve Lucas & Dilsher S. Dhoot. (2023) Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion. Eye.
Crossref
Crossref
Glenn Yiu, Denis Huang, Yinwen Wang, Zhe Wang, Ming Yang & Zdenka Haskova. (2023) Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion. American Journal of Ophthalmology 249, pages 74-81.
Crossref
Crossref
Daniel Duck-Jin Hwang & Hak Jun Lee. (2023) Long-term changes in the choroidal thickness in patients with unilateral central retinal vein occlusion. Scientific Reports 13:1.
Crossref
Crossref
Amy Y. Zhou, Brooklyn E. Taylor, Katherine G. Barber, Chieh A. Lee, Zakary R. R. Taylor, Scott J. Howell & Patricia R. Taylor. (2023) Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice. International Journal of Molecular Sciences 24:2, pages 1347.
Crossref
Crossref
Sandrine Laurance, Mickaël Marin & Yves Colin. (2023) Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?. International Journal of Molecular Sciences 24:2, pages 1072.
Crossref
Crossref
Su Xiaojuan, Li Xiaodong, Fu Zhongmei & Ye Hejiang. (2022) Chinese Herbal Medicine Combined with Intravitreal Antivascular Growth Factor Agents in Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis. Journal of Ophthalmology 2022, pages 1-13.
Crossref
Crossref
Paul Mitchell, Prabhjot Juneja, Chao Wang & Rebecca Schnabel. (2022) Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion. Clinical & Experimental Ophthalmology 50:9, pages 1097-1100.
Crossref
Crossref
Colin M. Xu, Erin Kim, Carolina C. S. Valentim, Kanika Seth, Justin C. Muste, Scott Perkins & Rishi P. Singh. (2022) Anti-Vascular Endothelial Growth Factor Treatment Patterns and Outcomes in Retinal Vein Occlusion in Routine Clinical Practice. Ophthalmic Surgery, Lasers and Imaging Retina 53:11, pages 626-633.
Crossref
Crossref
Yongseok Mun, ChulHyoung Park, Da Yun Lee, Tong Min Kim, Ki Won Jin, Seok Kim, Yoo-Ri Chung, Kihwang Lee, Ji Hun Song, Young-Jung Roh, Donghyun Jee, Jin-Woo Kwon, Se Joon Woo, Kyu Hyung Park, Rae Woong Park, Sooyoung Yoo, Dong-Jin Chang & Sang Jun Park. (2022) Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology. Scientific Reports 12:1.
Crossref
Crossref
Huimin Zhong & Xiaodong Sun. (2022) Contribution of Interleukin-17A to Retinal Degenerative Diseases. Frontiers in Immunology 13.
Crossref
Crossref
Yasha S. Modi, Lediana Goduni, Hadi Moini, Andrea Gibson, Nick Boucher, Genevieve Lucas & Dilsher S. Dhoot. (2021) Antivascular Endothelial Growth Factor Dosing Frequency and Visual Outcomes in Macular Edema Following Central Retinal Vein Occlusion. Journal of VitreoRetinal Diseases 5:6, pages 505-512.
Crossref
Crossref
Hongfang Yong, Hui Qi, Hongtao Yan, Qianqian Wu & Ling Zuo. (2021) The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 259:11, pages 3243-3250.
Crossref
Crossref
Weilin Song, Rishi P. Singh & Aleksandra V. Rachitskaya. (2021) The Effect of Delay in Care among Patients Requiring Intravitreal Injections. Ophthalmology Retina 5:10, pages 975-980.
Crossref
Crossref
M. Routier, J.-B. Ducloyer, H. Masse, O. Lebreton, P. Fossum, M. Clement & M. Weber. (2021) Étude rétrospective de vraie vie de patients traités par injections intra-vitréennes de dexaméthasone ou d’anti-VEGF pour œdèmes maculaires diabétiques ou secondaires à une occlusion veineuse rétinienne : à propos de 98 yeux. Journal Français d'Ophtalmologie 44:8, pages 1148-1158.
Crossref
Crossref
Terry Lee, Cason B. Robbins, Akshay S. Thomas & Sharon Fekrat. (2021) Treatment Patterns and Clinical Outcomes for Branch Retinal Vein Occlusion: An 8-Year Experience at a Tertiary Eye Center. Journal of VitreoRetinal Diseases 5:5, pages 412-419.
Crossref
Crossref
Scott J. Howell, Chieh A. Lee, Julia C. Batoki, Thomas E. Zapadka, Sarah I. Lindstrom, Brooklyn E. Taylor & Patricia R. Taylor. (2021) Retinal Inflammation, Oxidative Stress, and Vascular Impairment Is Ablated in Diabetic Mice Receiving XMD8-92 Treatment. Frontiers in Pharmacology 12.
Crossref
Crossref
Philip Hykin, A Toby Prevost, Sobha Sivaprasad, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit Yang, Simon P Harding, Andrew Lotery, Usha Chakravarthy & John Brazier. (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment 25:38, pages 1-196.
Crossref
Crossref
Robert J. Asaro & Pedro Cabrales. (2021) Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow. Diagnostics 11:6, pages 971.
Crossref
Crossref
Ian L McAllister, Lynne A Smithies, Fred K Chen, David A Mackey & Paul G Sanfilippo. (2021) Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy. BMJ Open Ophthalmology 6:1, pages e000728.
Crossref
Crossref
Şehnaz ÖZÇALIŞKAN & Yasin ÖZCAN. (2020) Evaluation of Neurodegenerative and Microvascular Changes in Branch Retinal Vein Occlusion After Regression of the Macular EdemaRetinal Ven Dal Tıkanıklığında Makula Ödeminin Gerilemesi Sonrası Mikrovasküler ve Nörodejeneratif Değişikliklerin İncelenmesi. Harran Üniversitesi Tıp Fakültesi Dergisi 17:3, pages 406-411.
Crossref
Crossref
Gianni Virgili, Gian Marco Tosi, Michele Figus, Stanislao Rizzo, Vittoria Murro, Dario Pasquale Mucciolo, Giuseppe Roberto & Rosa Gini. (2019) Use of anti-vascular endothelial growth factor drugs for eye disease in Tuscany: Development and test of indicators of treatment intensity. European Journal of Ophthalmology 30:6, pages 1440-1447.
Crossref
Crossref
Manuel AP Vilela. (2020) Use of Anti-VEGF Drugs in Retinal Vein Occlusions. Current Drug Targets 21:12, pages 1181-1193.
Crossref
Crossref
Ivan Seah, Xinxin Zhao, Qianyu Lin, Zengping Liu, Steven Zheng Zhe Su, Yew Sen Yuen, Walter Hunziker, Gopal Lingam, Xian Jun Loh & Xinyi Su. (2020) Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases. Eye 34:8, pages 1341-1356.
Crossref
Crossref
Thomas E. Zapadka, Sarah I. Lindstrom, Brooklyn E. Taylor, Chieh A. Lee, Jie Tang, Zakary R. R. Taylor, Scott J. Howell & Patricia R. Taylor. (2020) RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy. International Journal of Molecular Sciences 21:10, pages 3547.
Crossref
Crossref
Chiara Giuffrè, Maria Vittoria Cicinelli, Alessandro Marchese, Michele Coppola, Maurizio Battaglia Parodi & Francesco Bandello. (2020) Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 258:4, pages 787-793.
Crossref
Crossref
Elad Moisseiev & Anat Loewenstein. (2019) Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?. Eye 34:2, pages 219-220.
Crossref
Crossref
Jeannette Y. Stallworth, Akshay S. Thomas, Ryan Constantine, Sandra S. Stinnett & Sharon Fekrat. (2019) Treatment Patterns and Clinical Outcomes for Central Retinal Vein Occlusion in the Antivascular Endothelial Growth Factor Era. Journal of VitreoRetinal Diseases 4:1, pages 13-21.
Crossref
Crossref
Fen Tang, Fan Xu, Haibin Zhong, Xin Zhao, Mingliang Lv, Ke Yang, Chaolan Shen, Hui Huang, Jian Lv, Siming Zeng, Min Li & Qi Chen. (2019) Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmology 19:1.
Crossref
Crossref
James H. Powers, Akshay S. Thomas, Tahreem A. Mir, Jane S. Kim, Faith A. Birnbaum, Stephen P. Yoon, Kirin Khan, Maria Gomez-Caraballo & Sharon Fekrat. (2019) Impact and Implication of Fovea-Involving Intraretinal Hemorrhage after Acute Branch Retinal Vein Occlusion. Ophthalmology Retina 3:9, pages 760-766.
Crossref
Crossref
Maciej Gawęcki. (2019) Micropulse Laser Treatment of Retinal Diseases. Journal of Clinical Medicine 8:2, pages 242.
Crossref
Crossref